What Melkonian Capital Management does

Melkonian Capital Management (MCM) is an SEC-registered private investment management firm founded in 1998 and headquartered at 450 West 31st Street, New York City. The firm deploys capital across three asset classes — private equity, real estate, and public markets — through an opportunistic, bottom-up, research-driven approach that targets concentrated, high-conviction holdings. MCM partners with management teams to drive operational improvements, organic growth, and strategic acquisitions, with portfolio activity concentrated in healthcare/pharma and tech-enabled services. The firm is founder-controlled; Ryan Melkonian (Founder & Managing Partner, CFA, Cornell/Columbia MBA, previously a partner at W.P. Stewart overseeing $12B in AUM) chairs the investment committee and serves on boards of Sebela Pharmaceuticals and Beach Bay Holdings.

The firm's go-to-market is restricted to qualified purchasers and accredited investors, with capital raised through confidential private placement memoranda distributed via direct relationships and referrals rather than retail or intermediated channels. Investor reporting and capital account statements are delivered through the SS&C GlobalOp Secure Portal. Marketing is minimal: no active digital advertising, content marketing, or social presence; all investor access is gated by eligibility and subscription documentation. Revenue mechanics follow the standard alternatives structure — recurring management fees on committed or invested capital plus performance fees/carried interest on realized investment profits — but specific rates, minimums, and AUM are not publicly disclosed.

MCM operates with a small core team (five named principals plus a three-person advisory board; overall headcount band 51–100) and a track record of seven-figure and billion-dollar realizations, including the April 2024 sale of Avetta to EQT for approximately $3 billion, the 2020 sale of Eyevance to Santen for $225 million, the 2014 sale of Vidara to Horizon Pharma for $660 million, and the 2010 sale of Alaven Pharmaceutical to MEDA for $350 million. Operating geographies include North America and Saudi Arabia, with global real-estate investment activity. The firm has no proprietary software platforms, AI/ML capabilities, public listing, or disclosed external institutional ownership.

Name

Melkonian Capital Management

Legal name

Melkonian Capital Management LLC

Website

https://melkoniancapital.com

Company type

Private

Founded year

1998

Operating status

Operating

Headcount range

51–100 employees

Short description

Melkonian Capital Management is an SEC-registered private investment management firm founded in 1998 in New York City that deploys capital across private equity, real estate, and public markets on behalf of accredited and institutional investors, leveraging deep principal experience and a track record of billion-dollar realizations.

Ownership category

akta.pro rank

Product category

Alternative Asset Management

NAICS

Portfolio Management and Investment Advice (52394), Securities, Commodity Contracts, and Other Financial Investments and Related Activities (523)

SIC

Investment Advice (6282), Investors, Nec (6799)

akta.pro primary industry

Real Estate Portfolio & Fund Management (Institutional/REIT/PE) (BPAJAMAJ)

akta.pro secondary industries

Institutional Separate Accounts & SMAs (Mandates) (FSAAAGAL), Private Banking Advisory & Discretionary Portfolio Management (FSABADAD)

Keywords

• Alternative asset management
• Private equity management
• Real estate investment
• Multi-asset class investing
• SEC-registered investment management

Headquarters

HQ city

New York

HQ country

United States

HQ region

North America

Offices1 record

Markets served

GTM type

B2B

Offering type

Services

Cost components

Personnel, Operations, Technology or R&D, Marketing or Sales, Others

Revenue model

1. Management Fees: Standard private equity/alternatives management fee structure on committed or invested capital. Not publicly disclosed.
2. Performance Fees/Carried Interest: Incentive fees on investment profits typical of private equity structures. Not publicly disclosed.

Pricing tiers

Go-to-market motion1 record

Distribution channels1 record

Marketing channels1 record

Core offering

Melkonian Capital Management is an SEC-registered investment management firm that manages capital across private equity, real estate, and public markets on behalf of accredited investors and institutional clients. The firm deploys an opportunistic, bottom-up, research-driven approach to build concentrated portfolios of high-conviction holdings, partnering with management teams to create value through operational enhancements, organic growth, and strategic acquisitions.

Product overview

Melkonian Capital Management (MCM) is an SEC-registered investment management firm that operates as a single, unified offering rather than a platform with modular products. The firm manages investments across three asset classes: private equity, real estate, and public markets. Rather than offering distinct product modules, MCM provides investment management services as a whole, deploying capital through an opportunistic, bottom-up, research-driven approach to build concentrated portfolios of high-conviction holdings. The firm partners with management teams to create value via operational enhancements, organic growth, and strategic acquisitions. MCM does not offer discrete, named software products, platforms, or API-accessible tools to external customers.

Differentiator

Problem solved

Functional benefit

Products and services

• Private Equity Investment Management Opportunistic, research-driven deployment of capital into private equity positions, partnering with management teams to drive operational enhancements, organic growth, and strategic acquisitions. Targeted to accredited investors and institutional allocators via private placement.
• Real Estate Investment Management Commercial real estate investment and capital markets activities, including large-scale developments, portfolio and single-asset acquisitions, and capital markets transactions across North America and Saudi Arabia. Targeted to accredited investors and institutional allocators via private placement.
• Public Markets Investment Management Opportunistic, research-driven deployment of capital in public markets to complement private equity and real estate allocations. Targeted to accredited investors and institutional allocators via private placement.

Quantifiable outcome

• Successful exits including Avetta ($3.1B by EQT), Eyevance ($225M by Santen), Vidara ($660M by Horizon Pharma), Alaven Pharmaceutical ($350M by MEDA)

Named customers2 records

Segments2 records

Ideal customer profiles2 records

Technology focussed No

API detail

Has API

No

API docs

API detail

Core technology

AI maturity

App detail

Integration1 record

Partnerships

One partnership is on record.

• SS&C GlobalOpsupportingOthers · 11 March 2016Technology service provider for investor portal and capital account statement access. Investors access their account statements via the SS&C GlobalOp Secure Portal.

Scale indicators4 records

Recent moves11 records

Expansion highlights3 records

Broad incumbents

• Ares Management: Large diversified alternatives manager spanning credit, private equity, real estate and secondary funds. Directly comparable to MCM's multi-asset class PE/RE/public-markets approach, though at much greater scale.
• Brookfield Asset Management: Global large-cap alternatives manager with leading real estate and infrastructure franchises raising from sovereign and institutional LPs. Overlaps with MCM's real-asset operating expertise and Saudi/MENA deal flow.
• Blackstone: Largest global alternatives manager spanning PE, real estate, credit and hedge funds for institutional and private wealth clients. Comparable as the scale benchmark for an institutional multi-asset alternatives franchise like MCM.

Direct peers

• StepStone Group: Multi-manager private-markets platform offering fund-of-funds, co-investment, and separate accounts through both commingled and evergreen vehicles. Comparable as a smaller, multi-strategy alternatives manager serving institutional and private wealth clients.
• Grosvenor Capital Management: Chicago-based alternatives multi-manager offering fund-of-funds, co-investment, secondaries and direct sleeves across PE, RE and debt. Closely comparable end-markets (institutional LPs), product breadth and founder-led culture.
• Kayne Anderson Capital Advisors: US alternatives manager focused on energy, infrastructure, real estate, credit and growth equity, raising from institutional and high-net-worth investors. Overlaps with MCM on real-asset operating expertise and multi-strategy product mix.
• Harrison Street Capital: Alternatives-focused investment manager specialising in real estate, education, infrastructure and private credit for institutional clients. Closely comparable PE/RE institutional-fund structure and target LP base to MCM.
• New Mountain Capital: Mid-market private equity firm with deep healthcare and SaaS services expertise taking active, operational ownership stakes. Comparable to MCM's sector-heavy healthcare portfolio history and operating-partner model.

Emerging players

• Pomona Capital: Pioneer in private equity secondaries, offering funds, customised portfolios and direct co-investment programmes to institutional investors. Comparable as a focused alternatives manager with SME-scale and institutional LP relationships.
• Wafra/Capital Investment Companies: New York-based alternatives manager focused on private equity, real estate and infrastructure with strong Middle East sovereign ties. Directly comparable to MCM on US/MENA geographic footprint and multi-asset alternatives thesis.

Market position

Strengths5 records

Weaknesses5 records

Competitive moat4 records

Key risks6 records

Key highlights6 records

Customer concentration

Revenue estimate

Valuation estimate

Number of profiles

Profiles5 records

Funding overview

Funding rounds

Investors

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

M&A

Investments1 record

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Frequently asked questions about Melkonian Capital Management